Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|November 1, 2005
Endothelial function and its assessmentDirk C Felmeden, Gregory Y H LipThe Cochrane Database of Systematic Reviews|December 14, 2011
Antiplatelet agents and anticoagulants for hypertensionGregory Yh Lip, Dirk C Felmeden, Girish DwivediAmerican Journal of Hypertension|May 29, 2007
Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes TrialCharles G C Spencer, Dirk C Felmeden, Andrew D Blann, et al.Hypertension (Dallas, Tex. : 1979)|March 8, 2003
Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatmentDirk C Felmeden, Charles G C Spencer, Andrew D Blann, et al.American Journal of Hypertension|January 9, 2003
Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor managementDirk C Felmeden, Charles G C Spencer, Funmi M Belgore, et al.International Journal of Cardiology|April 20, 2004
Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes TrialCharles G C Spencer, Steven C Martin, Dirk C Felmeden, et al.The American Journal of Cardiology|August 14, 2003
Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT])Dirk C Felmeden, Charles G C Spencer, Natali A Y Chung, et al.Pageof 1